[Non-invasive assessment of coronary flow reserve--valuable functional information in cardiac workflow]

H Lambertz1, H Lethen, H-P Tries

  • 1Abteilung für Kardiologie, Deutsche Klinik für Diagnostik, Aukammallee 33, 65191 Wiesbaden, Germany. lambertz.kardio@dkd-wiesbaden.de

Zeitschrift Fur Kardiologie
|February 22, 2003
PubMed

Insights

Echocardiography non-invasively assesses coronary flow reserve (CFR) in the LAD and RCA. This method aids in planning procedures for coronary artery disease and monitoring treatment effectiveness.

Area of Science:

  • Cardiovascular Imaging
  • Diagnostic Ultrasound
  • Non-invasive Cardiology

Background:

  • Coronary flow reserve (CFR) is a crucial indicator of myocardial perfusion.
  • Traditional methods for CFR assessment can be invasive.
  • Non-invasive assessment of CFR is desirable for patient management.

Purpose of the Study:

  • To evaluate the feasibility and utility of echocardiography for determining coronary flow reserve (CFR).
  • To assess the role of CFR in guiding coronary artery disease management and prognosis.
  • To explore the application of CFR measurements in monitoring therapeutic interventions.

Main Methods:

  • Utilizing modern high-resolution ultrasound equipment for echocardiographic CFR assessment.
  • Employing high-frequency fundamental imaging or echo-contrast enhanced harmonic Doppler technology.
  • Correlating echocardiographic CFR findings with coronary morphology from heart catheterization.

Main Results:

  • Successful echocardiographic CFR determination in approximately 90% of LAD and over 70% of RCA assessments.
  • Demonstrated non-invasiveness and lack of radiation exposure as key advantages.
  • CFR measurements proved valuable in planning invasive procedures and estimating prognosis.

Conclusions:

  • Echocardiography provides a feasible and non-invasive method for assessing coronary flow reserve (CFR).
  • CFR assessment aids in clinical decision-making for coronary artery disease, including procedural planning and prognosis.
  • Serial CFR measurements can monitor microcirculatory function and treatment response.